A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
Sponsor and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health Clinical Center (CC)
Contact
Barbara Weinstein, R.N.
(301) 594-4180
weinsbar@nhlbi.nih.gov
Investigator
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier
NCT00217594
